Quality Improvement project to study the impact of clinical pharmacist in diabetic management of admitted cardiac patients

Abstract

Abstract Diabetes is a fast-growing chronic disease worldwide. Associated with high morbidity, mortality, and cost. Glycemic control in diabetic patients is a demanding issue and requires partnership with health care professionals. the clinical pharmacist has a positive contribution through a range of extended services to optimize diabetic management and improve patients outcome. Objectives: This study aims to investigate the role of the clinical pharmacist in the glycemic management of admitted diabetic cardiac patients at King Fahad Medical City. Method: This is a prospective, cohort study carried out at King Salman Cardiac Center of King Fahad Medical City, cardiac Patients admitted at the cardiac centerfrom October 2018 to October 2020 were randomly assigned to intervention (n= 500) or control group (n=500). Patients were recruited either in the intervention group ( group covered by a clinical pharmacist ) or the control group ( group not covered by a clinical pharmacist ). Follow-up started concurrently with data collection, Glycosylated hemoglobin (HbAC ), fasting blood glucose (FBG),and frequency of hypoglycemic episodes at baseline , and then 6 months after clinical pharmacist intervention Results: HbAC levels were reduced in both groups. For the intervention group, HbAC reduction was (8.5 from10.2 , SD= 2.2 ) , (p= 0.04 ). For the control group, HbAC reduction was 9.05 from 9.95 , SD= 1.95 , (p= 0.05) , FBG was decreased in intervention group by 29 mg\dl compared to non-statistical significant by 9 mg\dl decrease in control group . Both the t-test indicated that the HbAC difference was statistically significant. Conclusions: Clinical pharmacist has a positive impact on monitoring diabetes in admitted cardiac patients.